Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.55 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | SENP2 | Q9HC62 | 2/20 | 0.31 |
| ▸ | SENP1 | Q9P0U3 | 2/20 | 0.31 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.31 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.31 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.31 |
| ▸ | RARB | P10826 | 1/20 | 0.31 |
| ▸ | ACACB | O00763 | 1/20 | 0.30 |
| ▸ | ACACA | Q13085 | 1/20 | 0.30 |
| ▸ | SENP3 | Q9H4L4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29808709 | 0.98 | CYP3A4 (0.56) | CYP3A4TRPA1TDP1MAPK1TSHR | |
| SCHEMBL8596339 | 0.98 | CYP3A4 (0.56) | CYP3A4TRPA1TDP1MAPK1TSHR | |
| SCHEMBL8973448 | 0.89 | CYP3A4 (0.51) | CYP3A4TRPA1TDP1MAPK1TSHR | |
| SCHEMBL667517 | 0.88 | CYP3A4 (0.62) | CYP3A4TRPA1TDP1MAPK1TSHR | |
| SCHEMBL8589469 | 0.86 | CYP3A4 (0.49) | CYP3A4TRPA1TDP1MAPK1TSHR | |
| SCHEMBL432632 | 0.85 | CYP3A4 (0.59) | CYP3A4TRPA1TDP1MAPK1TSHR | |
| SCHEMBL2157655 | 0.85 | CYP3A4 (0.56) | CYP3A4TRPA1TDP1MAPK1TSHR | |
| SCHEMBL8596343 | 0.81 | CYP3A4 (0.55) | CYP3A4TRPA1TDP1MAPK1TSHR | |
| SCHEMBL7588494 | 0.81 | CA12 (0.47) | CYP3A4TRPA1TDP1MAPK1TSHR | |
| SCHEMBL18126138 | 0.80 | CYP3A4 (0.53) | CYP3A4TRPA1TDP1MAPK1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2414418-A1 | COMPOSITION CONTAINING A SURFACE-DEACTIVATED POLYISOCYANATE AND CURING IN TWO STAGES | Sika Technology AG (CH) | 2012-02-08 | — | — | EP | claimed |
| WO-2010112537-A1 | COMPOSITION CONTAINING A SURFACE-DEACTIVATED POLYISOCYANATE AND CURING IN TWO STAGES | SIKA TECHNOLOGY AG (CH) | 2010-10-07 | — | — | WO | claimed |
| JP-5250918-A | — | — | None | — | — | JP | disclosed |
| US-12261265-B2 | Method for producing lithium fluorosulfonate, lithium fluorosulfonate, nonaqueous electrolytic solution, and nonaqueous electrolytic solution secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-03-25 | — | — | US | disclosed |
| EP-3709426-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ENERGY DEVICE USING SAME | MITSUBISHI CHEM CORP (JP) | 2025-02-26 | — | — | EP | disclosed |
| US-20240154170-A1 | NONAQUEOUS ELECTROLYTE, NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, AND ENERGY DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-05-09 | — | — | US | disclosed |
| EP-3584872-B1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND POWER STORAGE DEVICE | MITSUBISHI CHEM CORP (JP) | 2023-10-25 | — | — | EP | disclosed |
| US-20230257500-A1 | RADICALLY POLYMERIZABLE COMPOSITIONS | BNY MELLON CORPORATE TRUSTEE SERVICES LIMITED, AS SECURITY AGENT (GB) | 2023-08-17 | — | — | US | disclosed |
| EP-4219400-A2 | METHOD FOR PRODUCING LITHIUM FLUOROSULFONATE, LITHIUM FLUOROSULFONATE, USE OF LITHIUM FLUOROSULFONATE IN A NONAQUEOUS ELECTROLYTIC SOLUTION, AND NONAQUEOUS ELECTROLYTIC SOLUTION | Mitsubishi Chemical Corporation (JP) | 2023-08-02 | — | — | EP | disclosed |
| US-11631895-B2 | Nonaqueous electrolyte solution and energy device using same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-04-18 | — | — | US | disclosed |
| EP-3782958-B1 | NONAQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY | MITSUBISHI CHEM CORP (JP) | 2023-03-01 | — | — | EP | disclosed |
| EP-0277376-B1 | AROMATIC AMIDE GROUPS-CONTAINING DIAMINES AND POLYMERS IN WHICH THESE DIAMINES ARE INCORPORATED | AKZO N.V. (NL) | 1991-02-27 | — | — | EP | disclosed |
| US-4980444-A | Polyamides, polyureas, polyimides; heat resistance, melt processability, high strength fibers, films | AKZO N.V. (NL) | 1990-12-25 | — | — | US | disclosed |
| EP-0328808-A2 | Polyurethane adhesive for a surface treatment-free fiber reinforced plastic | GENCORP INC. (US) | 1989-08-23 | — | — | EP | disclosed |
| US-4851562-A | HEAT RESISTANCE, MELT PROCESS ABILITY | AKZO N.V. (NL) | 1989-07-25 | — | — | US | disclosed |
| US-4806414-A | THERMOPLASTIC POLYMERS WITH POLYESTER-ESTER URETHANE ADHESIVES | AKZO NV (NL) | 1989-02-21 | — | — | US | disclosed |
| EP-0102115-B1 | POLYESTER-ESTER URETHANE | AKZO N.V. (NL) | 1987-06-10 | — | — | EP | disclosed |
| EP-0213681-A1 | Composite material | AKZO N.V. (NL) | 1987-03-11 | — | — | EP | disclosed |
| EP-0159053-A1 | Polyester-ester urethane | AKZO N.V. (NL) | 1985-10-23 | — | — | EP | disclosed |
| US-4483970-A | BLOCK POLYMERS, MOLDING MATERIALS | AKZO N.V. (NL) | 1984-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11631895-B2 | Nonaqueous electrolyte solution and energy device using same | SLC26A3, VDAC3, SLC25A13 | CYP3A4 4041/4885TRPA1 967/4885TDP1 3532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.